// App-Quantinova.ai

P1488 : ASSOCIATION BETWEEN HEMOGLOBIN LEVELS AND END-ORGAN DAMAGE IN SICKLE CELL DISEASE: A RETROSPECTIVE LINKED PRIMARY AND SECONDARY CARE DATABASE ANALYSIS IN ENGLAND

Researchers

Presenter

  • Paul Telfer

Principal Investigators

  • Anne Beaubrun

Medical Centers

  • London School of Hygiene and Tropical Medicine,London,Royaume-uni

  • Health iQ, CorEvitas,London,United Kingdom

  • Queen Mary, University of London,London,Royaume-uni

  • Global Blood Therapeutics, South San Francisco, CA

  • Queen Mary University of London,London,Vereinigtes Königreich

  • Health iQ, CorEvitas,London,Reino Unido

  • Health iQ, CorEvitas,London,Storbritannien

  • Global Blood Therapeutics,South San Francisco,Verenigde Staten

  • Health iQ, CorEvitas,London,Reino Unido

  • London School of Hygiene and Tropical Medicine, London, United Kingdom

  • Queen Mary University of London,London,Vereinigtes Königreich

  • London School of Hygiene and Tropical Medicine, London, United Kingdom

  • London School of Hygiene and Tropical Medicine,London,Vereinigtes Königreich

  • London School of Hygiene and Tropical Medicine, London, United Kingdom

  • Global Blood Therapeutics, South San Francisco, CA

  • Queen Mary University of London, London, United Kingdom

  • Health iQ, CorEvitas,London,Royaume-uni

  • Global Blood Therapeutics,South San

  • Queen Mary, University of London,London,Regno Unito

  • Global Blood Therapeutics,South San Francisco,Verenigde Staten

  • Global Blood Therapeutics, South San Francisco, CA, United States.

  • Queen Mary, University of London,London,Regno Unito

  • Health iQ, CorEvitas,London,Verenigd Koninkrijk

  • Global Blood Therapeutics,South San Francisco,Estados Unidos

  • London School of Hygiene and Tropical Medicine, London, United Kingdom

  • Health iQ, CorEvitas,London,Соединённое Королевство

  • Health iQ, CorEvitas,London,Vereinigtes Königreich

Locations

  • United Kingdom

  • India

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Sickle cell anemia

Biomarkers

  • Stearoyl-CoA desaturase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved